Chemoinformaics analysis of 6,7-DIHYDROXYCOUMARIN
| Molecular Weight | 178.143 | nRot | 0 |
| Heavy Atom Molecular Weight | 172.095 | nRig | 12 |
| Exact Molecular Weight | 178.027 | nRing | 2 |
| Solubility: LogS | -2.377 | nHRing | 1 |
| Solubility: LogP | 0.911 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 6 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 9 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 10 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 11 |
| nHA | 4 | APOL | 22.2388 |
| nHD | 2 | BPOL | 8.62324 |
| QED | 0.469 |
| Synth | 2.18 |
| Natural Product Likeliness | 1.028 |
| NR-PPAR-gamma | 0.076 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.937 |
| HIA | 0.012 |
| CACO-2 | -4.765 |
| MDCK | 0.0000124 |
| BBB | 0.031 |
| PPB | 0.852065 |
| VDSS | 0.487 |
| FU | 0.198294 |
| CYP1A2-inh | 0.91 |
| CYP1A2-sub | 0.74 |
| CYP2c19-inh | 0.053 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.061 |
| CYP2c9-sub | 0.757 |
| CYP2d6-inh | 0.472 |
| CYP2d6-sub | 0.609 |
| CYP3a4-inh | 0.434 |
| CYP3a4-sub | 0.151 |
| CL | 16.579 |
| T12 | 0.882 |
| hERG | 0.049 |
| Ames | 0.12 |
| ROA | 0.099 |
| SkinSen | 0.921 |
| Carcinogencity | 0.721 |
| EI | 0.979 |
| Respiratory | 0.301 |
| NR-Aromatase | 0.092 |
| Antiviral | No |
| Prediction | 0.76216 |